Hodgkin's disease: treatment of relapsed disease.
Cavalli
F G
FG
Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D005260:Female; D006689:Hodgkin Disease / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods*; D012008:Recurrence; D018570:Risk Assessment; D016879:Salvage Therapy; D015996:Survival Rate; D016896:Treatment Outcome